Stock 688133 SHANGHAI TITAN SCIENTIFIC CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Shanghai Titan Scientific Co., Ltd.

Equities

688133

CNE100005XG3

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 18/06/2024 BST 		5-day change 1st Jan Change
24.88 CNY -0.40% Intraday chart for Shanghai Titan Scientific Co., Ltd. -1.58% -46.32%
05-08 Shanghai Titan Scientific Co., Ltd. commences an Equity Buyback Plan for CNY 15 million worth of its shares, under the authorization approved on April 8, 2024. CI
04-29 Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • The company appears to be poorly valued given its net asset value.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
SHANGHAI TITAN SCIENTIFIC CO., LTD. Stock Shanghai Titan Scientific Co., Ltd.
-46.32% 403M -
ECOLAB INC. Stock Ecolab Inc.
+22.66% 69.48B
A-
SIKA AG Stock Sika AG
-4.42% 46.58B
A-
GIVAUDAN SA Stock Givaudan SA
+24.23% 44.61B
B+
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+30.58% 28.14B
A-
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+8.81% 19.39B
C+
SYMRISE AG Stock Symrise AG
+14.76% 17.08B
B+
CELANESE CORPORATION Stock Celanese Corporation
-10.45% 15.2B
B+
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-25.49% 14.99B
A-
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A. Stock Sociedad Química y Minera de Chile S.A.
-30.99% 11.87B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. 688133 Stock
  4. Ratings Shanghai Titan Scientific Co., Ltd.